GyroStim for Value Based Care Organizations

Better Outcomes. Lower Costs. Increased Shared Savings.

As healthcare rapidly transitions from Fee-for-Service to Value-Based Care under CMS-led reimbursement reform, preserving and restoring functional independence has become one of the most effective strategies for improving patient outcomes while reducing the total cost of care. Preventing falls, maintaining mobility, preserving cognition, and supporting lifelong independence are no longer just clinical goals—they are strategic priorities for value-based healthcare organizations.

GyroStim's FDA-cleared, Breakthrough Device-designated precision neurotechnology directly supports those objectives by restoring and optimizing the neurological foundation of mobility, balance, cognition, and functional independence—reducing falls, preventable complications, and healthcare utilization while transforming neurological rehabilitation into a more effective, efficient, and scalable model of care with the potential to contribute significantly to shared savings.

GyroStim converts time intensive, high-cost neurorehabilitation
into effective, efficient, high-margin care.

One of GyroStim's greatest advantages is its ability to dramatically accelerate neurological recovery. In retrospective clinical analyses of patients with vestibular dysfunction, GyroStim-assisted neurorehabilitation was associated with up to a fourfold greater weekly therapeutic dose-response than standard of care (SOC) alone across multiple validated balance measures. Rather than simply improving outcomes, GyroStim has the potential to help patients regain meaningful function in a fraction of the time required by conventional rehabilitation.

The impact extends far beyond rehabilitation. Earlier restoration of balance, mobility, and neurological function has the potential to reduce fall risk, resulting in fewer falls, fewer fall-related injuries and hospitalizations, and lower downstream healthcare utilization. By interrupting this costly cascade of complications, GyroStim helps reduce total cost of care while preserving patient independence and quality of life.

For Value-Based Care organizations, this creates a powerful economic advantage. By accelerating recovery, reducing fall-related complications, and lowering downstream healthcare costs, GyroStim has the potential to transform neurological rehabilitation from a traditional cost center into a strategic driver of population health, lower total cost of care, and greater shared savings.

Clinical data provided by Kim Fox, DPT - Clinical Director & Founder, AVORA Health

More than a medical device—

GyroStim transforms better clinical outcomes into greater shared savings.

GyroStim is the world's only multimodal neurorehabilitation system to receive both FDA clearance and the FDA's prestigious Breakthrough Device designation.

FDA clearance reflects GyroStim's demonstrated safety and effectiveness, while the FDA's Breakthrough Device designation recognizes its potential to meaningfully improve the treatment of debilitating vestibular dysfunction and balance disorders across a wide range of neurological conditions.

For Value-Based Care organizations, these distinctions represent far more than regulatory checkmarks—they provide important regulatory validation of a technology uniquely positioned to support the core objectives of outcomes-based healthcare: improving patient outcomes, reducing preventable healthcare utilization, lowering total cost of care, and maximizing shared savings.

In an increasingly outcomes-driven healthcare system, GyroStim is far more than an innovative rehabilitation technology—it is a strategic clinical asset capable of delivering measurable value for patients, providers, and healthcare organizations alike.
GyroStim transforms the economics of neurological care by converting resource-intensive patient populations into high-value opportunities through:

Better patient outcomes

Increased patient throughput

Lower total cost of care

Improved utilization of personnel and infrastructure

Greater shared savings

Stronger return on capital investment

Every improvement in recovery efficiency creates value across the healthcare organization. By accelerating recovery, increasing patient throughput, and expanding clinical capacity without proportional increases in staffing or infrastructure, GyroStim lowers total cost of care while improving the productivity of existing clinical resources.

The result is greater shared savings, stronger return on investment, and a strategic capital investment that delivers measurable clinical, operational, and financial value year after year.
Healthcare's most resource-intensive patient populations represent one of the greatest opportunities to improve both clinical and financial performance under Value-Based Care. GyroStim helps transform these high-cost populations into high-value opportunities by improving outcomes, reducing total cost of care, and increasing shared savings.

Target populations include:

Concussion and mild traumatic brain injury (mTBI)

Vestibular dysfunction and balance disorders

Fall-risk and older adult populations

Stroke and neurological impairment

Chronic neurodegenerative and post-viral conditions

Many of these patients are among the most difficult to rehabilitate. Severe balance impairment, neurological dysfunction, cognitive deficits, frailty, and fatigue often limit their ability to participate effectively in conventional rehabilitation—contributing to prolonged recovery, preventable complications, and escalating healthcare costs.

GyroStim was engineered to overcome these limitations. By expanding access to advanced neurological rehabilitation for many low-functioning patients, GyroStim has the potential to accelerate recovery, reduce falls and downstream complications, lower total cost of care, and transform one of healthcare's highest-cost patient populations into one of its greatest opportunities for value creation and shared savings.
GyroStim helps value-based healthcare organizations:

Differentiate with breakthrough neurological rehabilitation

Attract patients, providers, and referral partners

Improve patient satisfaction and experience

Increase provider engagement and network loyalty

Strengthen continuity of care across the organization

Reduce leakage to competing health systems

Preserve revenue and maximize shared savings opportunities

In Value-Based Care, competitive differentiation is about more than reputation—it's about delivering capabilities that keep patients within the network.

GyroStim's breakthrough technology differentiates healthcare organizations by expanding access to advanced neurological care, strengthening referral pathways, reducing patient leakage, and transforming clinical innovation into measurable economic advantage.
By compressing recovery timelines from months to weeks, GyroStim has the potential to reduce:

Repeat visits and extended treatment cycles

Specialist consultations and referrals

Diagnostic imaging utilization

Medication utilization and dependence

Downstream healthcare utilization

Time spent at elevated risk for falls and fall-related complications

Total cost per episode of care

By accelerating recovery and restoring function more efficiently, GyroStim reduces the time, resources, and healthcare utilization required to achieve meaningful clinical improvement. Shorter episodes of care, combined with a reduced period of vulnerability to falls and other preventable complications, can translate directly into lower total cost of care.
GyroStim has demonstrated recovery rates many times faster than conventional care, creating a compelling value proposition for Value-Based Care organizations.

Shorter episodes of care

Lower cost per episode

Increased clinical capacity

Greater patient access

Improved patient satisfaction

Reduced risk of preventable complications

Lower downstream healthcare utilization

More patients treated with the same clinical resources

Greater shared savings and financial performance

Every week removed from the recovery timeline creates value. Faster recovery reduces resource utilization, expands treatment capacity, lowers total cost of care, and enables healthcare organizations to treat more patients without increasing infrastructure or staffing.

Shorter episodes → Lower cost → Greater capacity → More patients treated → Higher shared savings.

In Value-Based Care, faster recovery doesn't simply improve efficiency—it multiplies value.
GyroStim complements existing rehabilitation strategies by extending—not replacing—the expertise of skilled clinicians. Its standardized, protocol-driven design enables healthcare organizations to scale advanced neurological rehabilitation across entire provider networks while preserving the flexibility of local clinical practice.

Standardized

Protocol-driven

Repeatable

Reproducible

Data-driven

Scalable

Whether deployed in hospitals, outpatient rehabilitation centers, specialty clinics, or integrated health systems, GyroStim integrates seamlessly into existing rehabilitation workflows while delivering consistent, high-quality neurological care through standardized treatment protocols and objective outcome measures.

The result is a scalable model of care that strengthens clinical consistency, operational efficiency, and Value-Based Care performance across the enterprise.
Many of the patients who need neurological rehabilitation the most are also the least able to participate in conventional therapy. GyroStim was engineered to overcome this barrier by expanding access to advanced multimodal neurorehabilitation for patients with:

Concussion and mild traumatic brain injury (mTBI)

Vestibular dysfunction and balance disorders

Stroke and neurological impairment

Fall-risk and older adult populations

Chronic neurodegenerative and post-viral conditions

As the world's only FDA-cleared, Breakthrough Device-designated multimodal neurorehabilitation system, GyroStim enables many low-functioning patients to access advanced neurological therapy that may otherwise be difficult to deliver through conventional rehabilitation alone.

By expanding access to the patients who need it most, GyroStim has the potential to accelerate recovery, reduce falls and downstream complications, lower healthcare utilization, and improve both clinical and economic outcomes.
By accelerating recovery up to 4 times faster, GyroStim has the potential to interrupt the cascade of downstream events that drive long-term healthcare utilization and cost.

Reduced fall risk and fall-related complications

Fewer specialist referrals and repeat evaluations

Reduced diagnostic imaging

Lower reliance on prolonged chronic care pathways

Reduced long-term burden of persistent post-concussion symptoms

Fewer emergency department visits and hospitalizations

Lower overall healthcare utilization

Every preventable downstream event avoided preserves clinical resources, reduces total cost of care, and creates greater value for patients, providers, and Value-Based Care organizations.
Value-Based Care demands more than treatment—it demands measurable outcomes. GyroStim provides objective, quantifiable data that helps organizations demonstrate clinical improvement, validate quality, and support value-based reimbursement:

Objective functional outcomes

Real-time treatment metrics

Standardized, protocol-driven care

Quantifiable patient improvement

Quality reporting support

Value-based reimbursement documentation

Evidence for payer negotiations

Better data leads to better decisions, better outcomes, and greater value.
GyroStim is uniquely positioned to help healthcare organizations achieve the three outcomes that define success in Value-Based Care:

Better patient outcomes

Lower total cost of care

Greater shared savings

GyroStim's technological advantages align remarkably well with the objectives of Value-Based Care.

By improving outcomes, reducing downstream healthcare utilization, expanding access to advanced neurological rehabilitation, increasing operational efficiency, and lowering total cost of care, GyroStim creates multiple pathways to value—helping healthcare organizations improve quality, strengthen financial performance, and maximize shared savings.